MedTrace Logo

EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice

NCT03494023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 539

Last updated 2020-04-28

No results posted yet for this study

Summary

The main objective of the study is to evaluate the size of the common bile duct (CBD) in a large cohort of patients with jaundice secondary to pancreatic head or distal bile duct malignancy undergoing diagnostic EUS for tissue acquisition or evaluation of resectability and to establish factors associated with a dilation of the CBD greater than 15mm.

Conditions

  • Pancreatic Cancer
  • Cholangiocarcinoma of the Extrahepatic Bile Duct
  • Ampulla of Vater Cancer
  • Jaundice, Obstructive

Interventions

DIAGNOSTIC_TEST

Endoscopic ultrasound

Measurement of the common bile duct diameter

Sponsors & Collaborators

  • Catholic University, Italy

    collaborator OTHER

  • Clinical Hospital Colentina

    lead OTHER

Principal Investigators

  • Mihai Rimbas, MD, PhD · Clinical Hospital Colentina

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-27
Primary Completion
2019-12-31
Completion
2020-04-15

Countries

  • Romania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03494023 on ClinicalTrials.gov